Parkway Life REIT - DBS Research 2026-05-22: A DPU Compounder In The Making

• Parkway Life REIT (SGX:C2PU) remains one of our preferred picks in the sector and is becoming increasingly attractive at current valuations. It's the only S-REIT with income visibility through to 2042.

Mount Elizabeth Orchard Hospital (MEH) – a heavyweight in Parkway Life REIT’s portfolio.

• - Read this at SGinvestors.io -
• - Read this at SGinvestors.io -

• We believe the Orchard precinct is particularly attractive to international patients and their families due to its extensive surrounding retail and hospitality offerings.

Completion of Project Renaissance, a major 3-year asset enhancement initiative (AEI) for MEH.

• Read more at SGinvestors.io.

Above is an excerpt from a report by DBS Group Research.
Clients of DBS may access the full PDF report @ https://www.dbs.com/insightsdirect/.

Previous report by DBS:
2026-02-02 Parkway Life REIT - FY26 To Lay Groundwork For The Next Leg.

Price targets by 2 other brokers at Parkway Life REIT Target Prices.

Listing of research reports at Parkway Life REIT Analyst Reports.

Relevant links:
Parkway Life REIT Share Price History,
Parkway Life REIT Announcements,
Parkway Life REIT Dividend Payout Dates & Corporate Actions,
Parkway Life REIT News